Man Group PLC Pfizer Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Pfizer Inc stock. As of the latest transaction made, Man Group PLC holds 2,956,275 shares of PFE stock, worth $76.3 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,956,275

Previous 1,575,014 87.7%

Holding current value

$76.3 Million

Previous $44.1 Million 94.14%

% of portfolio

0.24%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $38.3 Million - $43.4 Million	1,381,261 Added 87.7%	2,956,275 $85.6 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $35.7 Million - $41.8 Million	-1,413,720 Reduced 47.3%	1,575,014 $44.1 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $58.2 Million - $66.8 Million	2,247,138 Added 303.01%	2,988,734 $82.9 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $3.57 Million - $4.64 Million	-136,704 Reduced 15.56%	741,596 $21.4 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $6.23 Million - $7.28 Million	194,058 Added 28.36%	878,300 $29.1 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $2.58 Million - $2.99 Million	-71,469 Reduced 9.46%	684,242 $25.1 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $41.1 Million - $53.5 Million	-1,043,074 Reduced 57.99%	755,711 $30.8 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $39.3 Million - $51.3 Million	942,135 Added 109.98%	1,798,785 $92.2 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $575,619 - $702,686	13,154 Added 1.56%	856,650 $37.5 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $65.6 Million - $77.8 Million	-1,410,451 Reduced 62.58%	843,496 $44.2 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $76.9 Million - $95.3 Million	1,680,347 Added 292.95%	2,253,947 $117 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $31.2 Million - $46.2 Million	-754,058 Reduced 56.8%	573,600 $33.9 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $43.9 Million - $56.4 Million	-1,118,458 Reduced 45.72%	1,327,658 $57.1 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $48.5 Million - $55 Million	1,351,189 Added 123.4%	2,446,116 $95.8 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $14.7 Million - $16.6 Million	438,789 Added 66.87%	1,094,927 $39.7 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $44.1 Million - $56 Million	-1,316,782 Reduced 66.74%	656,138 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $31.9 Million - $37.4 Million	1,005,129 Added 103.86%	1,972,920 $72.4 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $3.59 Million - $4.36 Million	-119,335 Reduced 10.98%	967,791 $31.6 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $18 Million - $25.7 Million	665,415 Added 157.79%	1,087,126 $35.5 Million
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $4.23 Million - $4.8 Million	128,561 Added 43.86%	421,711 $16.5 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $3.55 Million - $4.61 Million	-109,411 Reduced 27.18%	293,150 $10.5 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $1.56 Million - $1.75 Million	-42,098 Reduced 9.47%	402,561 $17.4 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $6.19 Million - $6.8 Million	-165,047 Reduced 27.07%	444,659 $18.9 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $6.92 Million - $7.89 Million	-179,912 Reduced 22.78%	609,706 $26.6 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $2.37 Million - $2.87 Million	68,637 Added 9.52%	789,618 $34.8 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $3.78 Million - $4.03 Million	-114,574 Reduced 13.71%	720,981 $26.2 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $26.7 Million - $30.9 Million	835,555 New	835,555 $29.7 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account